Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PANK3 | Q9H999 | 7/20 | 0.44 |
| ▸ | DPP4 | P27487 | 3/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.44 |
| ▸ | DPP7 | Q9UHL4 | 3/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.44 |
| ▸ | PREP | P48147 | 1/20 | 0.43 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.42 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.42 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.41 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2691675 | 1.00 | PANK3 (0.44) | PANK3DPP4DPP8DPP9DPP7 | |
| SCHEMBL2691679 | 1.00 | PANK3 (0.44) | PANK3DPP4DPP8DPP9DPP7 | |
| SCHEMBL1844336 | 0.82 | PANK3 (0.49) | PANK3DPP4DPP8DPP9DPP7 | |
| SCHEMBL26128961 | 0.77 | PANK3 (0.45) | PANK3DPP4DPP8DPP9DPP7 | |
| Trifluoroacetic Acid SCHEMBL2694917 | 0.74 | DPP4 (0.59) | PANK3DPP4DPP8DPP9DPP7 | |
| Trifluoroacetic Acid SCHEMBL2694915 | 0.74 | DPP4 (0.59) | PANK3DPP4DPP8DPP9DPP7 | |
| SCHEMBL4789103 | 0.74 | DPP4 (0.50) | PANK3DPP4DPP8DPP9DPP7 | |
| SCHEMBL18701863 | 0.73 | CHRM1 (0.52) | PANK3DPP4DPP8DPP9DPP7 | |
| SCHEMBL4898809 | 0.72 | KDM4E (0.47) | PANK3DPP4DPP8DPP9DPP7 | |
| SCHEMBL4757514 | 0.72 | KDM4E (0.47) | PANK3DPP4DPP8DPP9DPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120108565-A1 | PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS | RANBAXY LABORATORIES LIMITED (IN) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120108565-A1 | PYRROLE CARBOXYLIC ACID DERIVATIVES AS ANTIBACTERIAL AGENTS | POLI, POLB, POLA1 | PANK3 224/4885DPP4 823/4885DPP8 1730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.